Champions Oncology Inc (CSBR)

Finanzdaten der Champions Oncology Inc-Aktie (CSBR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-07-31	2026-04-30	2026-01-31	2025-10-31	2025-07-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.10%15.23	13.84	16.56	15.04	14.00
Cost Of Revenue	10.63%7.53	6.81	8.83	7.26	8.00
	10.83%2.34	2.12	2.27	-	-
Research and Development	10.83%2.34	2.12	2.27	-	-
Depreciation and Amortization	2.18%0.31	0.32	0.34	0.36	0.36
Operating Income/Loss	21.65%-0.41	-0.52	-0.28	0.19	-0.53
Income/Loss From Continuing Operations Before Tax	16.16%-0.42	-0.50	-0.24	0.26	-0.45
Income Tax Expense/Benefit, Current	0.01	-	-	-	0.01
Income Tax Expense/Benefit	93.60%0.01	0.17	0.04	0.02	0.01
	36.13%-0.43	-0.67	-0.28	0.24	-0.47
Attributable To Parent	36.13%-0.43	-0.67	-0.28	0.27	-0.44
Basic Average Shares	13.90	-	13.89	13.79	13.79
Basic Earnings Per Share	-0.03	-	-0.02	0.02	-0.03